Injective vs Monad
Compare Injective and Monad on TVL, fees, revenue and activity to understand how these projects stack up.
$9.23M
Injective is a Cosmos‑SDK Layer‑1 with on‑chain order books, zero‑gas trading and a frequent batch auction that mitigates MEV. Its built‑in Ethereum bridge lets users bring ERC‑20s without custodial risk, and the WasmX module supports CosmWasm smart contracts. INJ holders can stake or participate in governance that controls upgrades like the 2024 Volan hard fork which added liquid staking.
View Full Page$955.16M
Monad is an Ethereum-compatible Layer-1 focused on high throughput, low fees and scalable decentralization. Its architecture targets 10,000 TPS with sub-second finality while preserving bytecode-level EVM compatibility, so Solidity contracts, wallets and infrastructure can work without major rewrites. The MON token is tracked by CoinGecko as the network's associated asset.
View Full PageKey Metrics Comparison
Injective
TVL$9.23M
24h Volume$56.3K
24h Fees$21.3K
24h Revenue$21.3K
30d Fees$487.4K
30d Revenue$487.4K
7d TVL Change-15.17%
Dominance0.00%
Monad
TVL$955.16M
24h Volume$94.33M
24h Fees$64.8K
24h Revenue$13.9K
30d Fees$4.03M
30d Revenue$1.14M
7d TVL Change+2.68%
Dominance0.34%
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
TVL Share
Share of combined TVL
Injective
1.0%Monad
99.0%Volume Share
Share of combined 24h volume
Injective
1.0%Monad
99.9%Fees Share
Share of combined 24h fees
Injective
24.8%Monad
75.2%Revenue Share
Share of combined 24h revenue
Injective
60.6%Monad
39.4%7d TVL Performance
TVL change over last 7 days
Injective
-15.17%Monad
2.68%Dominance
Market dominance by TVL
Injective
0.0%Monad
0.3%TVL Comparison
Injective
Monad